1. Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep 2020;10:14790.
Article PubMed PMC
2. Jung CH, Son JW, Kang S, Kim WJ, Kim HS, Kim HS, et al. Diabetes fact sheets in Korea, 2020: an appraisal of current status. Diabetes Metab J 2021;45:1-10.
Article PubMed PMC
3. Viana LV, Leitao CB, Kramer CK, Zucatti AT, Jezini DL, Felicio J, et al. Poor glycaemic control in Brazilian patients with type 2 diabetes attending the public healthcare system: a cross-sectional study. BMJ Open 2013;3:e003336.
Article PubMed PMC
4. Lu J, Weng J, Gu W, Guo X, Yang W, Zou D, et al. Non-pharmaceutical factors for poor glycemic control in 13,970 Chinese women with drug-treated type 2 diabetes: a cross-sectional survey in 77 tertiary hospitals in four Chinese cities. Patient Prefer Adherence 2014;8:1161-7.
PubMed PMC
5. Aronson R, Orzech N, Ye C, Goldenberg R, Brown V. Specialist-led diabetes registries and predictors of poor glycemic control in type 2 diabetes: insights into the functionally refractory patient from the LMC Diabetes Registry database. J Diabetes 2016;8:76-85.
Article PubMed
6. Haghighatpanah M, Nejad A, Haghighatpanah M, Thunga G, Mallayasamy S. Factors that correlate with poor glycemic control in type 2 diabetes mellitus patients with complications. Osong Public Health Res Perspect 2018;9:167-74.
Article PubMed PMC
7. Kayar Y, Ilhan A, Kayar NB, Unver N, Coban G, Ekinci I, et al. Relationship between the poor glycemic control and risk factors, life style and complications. Biome Res 2017;28:1581-6.
8. Lima RF, Fontbonne A, Carvalho EM, Montarroyos UR, Barreto MN, Cesse EA. Factors associated with glycemic control in people with diabetes at the Family Health Strategy in Pernambuco. Rev Esc Enferm USP 2016;50:937-45.
Article PubMed
9. Cai X, Hu D, Pan C, Li G, Lu J, Ji Q, et al. The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes: a nationwide prospective cohort study. Sci Rep 2019;9:7709.
Article PubMed PMC PDF
10. Franzini L, Ardigo D, Cavalot F, Miccoli R, Rivellese AA, Trovati M, et al. Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology. Nutr Metab Cardiovasc Dis 2013;23:235-41.
Article PubMed
11. Al-Azzam SI, Khabour OF, Alzoubi KH, Mukattash TL, Ghanma M, Saleh H. The role of adiponectin gene variants in glycemic control in patients with type 2 diabetes. Endocr Res 2014;39:13-7.
Article PubMed
12. Zhang X, Sun J, Han W, Jiang Y, Peng S, Shan Z, et al. The type 2 deiodinase Thr92Ala polymorphism is associated with worse glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. J Diabetes Res 2016;2016:5928726.
Article PubMed PMC PDF
13. Rotroff DM, Yee SW, Zhou K, Marvel SW, Shah HS, Jack JR, et al. Genetic variants in CPA6 and PRPF31 are associated with variation in response to metformin in individuals with type 2 diabetes. Diabetes 2018;67:1428-40.
Article PubMed PMC
14. Cho SB, Jang JH, Chung MG, Kim SC. Exome chip analysis of 14,026 Koreans reveals known and newly discovered genetic loci associated with type 2 diabetes mellitus. Diabetes Metab J 2021;45:231-40.
Article PubMed PMC
15. Kim Y, Han BG; KoGES group. Cohort profile: the Korean Genome and Epidemiology Study (KoGES) consortium. Int J Epidemiol 2017;46:e20.
Article PubMed PMC
16. Jones BL, Nagin DS, Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res 2001;29:374-93.
Article
17. Baumgartner SE, Leydesdorff L. Group-based trajectory modeling (GBTM) of citations in scholarly literature: dynamic qualities of “transient” and “sticky knowledge claims”. J Am Soc Inf Sci Technol 2014;65:797-811.
Article
18. Andruff H, Carraro N, Thompson A, Gaudreau P, Louvet B. Latent class growth modelling: a tutorial. Tutor Quant Methods Psychol 2009;5:11-24.
Article
19. Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, de Gaetano G. Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis. J Am Coll Cardiol 2010;55:1339-47.
PubMed
20. Wang T, Huang T, Heianza Y, Sun D, Zheng Y, Ma W, et al. Genetic susceptibility, change in physical activity, and long-term weight gain. Diabetes 2017;66:2704-12.
Article PubMed PMC
21. Knol MJ, VanderWeele TJ. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol 2012;41:514-20.
Article PubMed PMC
22. Tuerxunyiming M, Mohemaiti P, Wufuer H, Tuheti A. Association of rs7754840 G/C polymorphisms in CDKAL1 with type 2 diabetes: a meta-analysis of 70141 subjects. Int J Clin Exp Med 2015;8:17392-405.
PubMed PMC
23. Deshmukh HA, Madsen AL, Vinuela A, Have CT, Grarup N, Tura A, et al. Genome-wide association analysis of pancreatic beta-cell glucose sensitivity. J Clin Endocrinol Metab 2021;106:80-90.
Article PubMed PMC
24. Ryoo H, Woo J, Kim Y, Lee C. Heterogeneity of genetic associations of CDKAL1 and HHEX with susceptibility of type 2 diabetes mellitus by gender. Eur J Hum Genet 2011;19:672-5.
Article PubMed PMC
25. Klimentidis YC, Lemas DJ, Wiener HH, O’Brien DM, Havel PJ, Stanhope KL, et al. CDKAL1 and HHEX are associated with type 2 diabetes-related traits among Yup’ik people. J Diabetes 2014;6:251-9.
PubMed
26. Peng F, Hu D, Gu C, Li X, Li Y, Jia N, et al. The relationship between five widely-evaluated variants in CDKN2A/B and CDKAL1 genes and the risk of type 2 diabetes: a meta-analysis. Gene 2013;531:435-43.
Article PubMed
27. Nfor ON, Wu MF, Lee CT, Wang L, Liu WH, Tantoh DM, et al. Body mass index modulates the association between CDKAL1 rs10946398 variant and type 2 diabetes among Taiwanese women. Sci Rep 2018;8:13235.
Article PubMed PMC
28. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial. Diabetologia 2004;47:1175-87.
Article PubMed
29. Schroner Z, Javorsky M, Tkacova R, Klimcakova L, Dobrikova M, Habalova V, et al. Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes. Diabetes Obes Metab 2011;13:89-91.
Article
30. Soltani G, Hatefi Z, Salehi AR, Khosravi S, Ghiasi MR, Teke K, et al. Pharmacogenomics of sulfonylureas response in relation to rs7754840 polymorphisms in cyclin-dependent kinase 5 regulatory subunit-associated protein 1-like (CDKAL1) gene in Iranian type 2 diabetes patients. Adv Biomed Res 2018;7:96.
Article PubMed PMC
31. Schroner Z, Javorsky M, Haluskova J, Klimcakova L, Babjakova E, Fabianova M, et al. Variation in CDKAL1 gene is associated with therapeutic response to sulphonylureas. Physiol Res 2012;61:177-83.
Article PubMed
32. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
Article PubMed
33. Liu NJ, Xiong Q, Wu HH, Li YL, Yang Z, Tao XM, et al. The association analysis polymorphism of CDKAL1 and diabetic retinopathy in Chinese Han population. Int J Ophthalmol 2016;9:707-12.
Article PubMed PMC
34. Jialal I, Amess W, Kaur M. Management of hypertriglyceridemia in the diabetic patient. Curr Diab Rep 2010;10:316-20.
Article PubMed PMC
35. Zhao J, Zhang Y, Wei F, Song J, Cao Z, Chen C, et al. Triglyceride is an independent predictor of type 2 diabetes among middle-aged and older adults: a prospective study with 8-year follow-ups in two cohorts. J Transl Med 2019;17:403.
Article PubMed PMC
36. Zheng D, Dou J, Liu G, Pan Y, Yan Y, Liu F, et al. Association between triglyceride level and glycemic control among insulintreated patients with type 2 diabetes. J Clin Endocrinol Metab 2019;104:1211-20.
Article PubMed
37. Ye X, Kong W, Zafar MI, Chen LL. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol 2019;18:48.
Article PubMed PMC
38. Choi SW, Mak TS, O’Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc 2020;15:2759-72.
Article PubMed PMC
39. Spracklen CN, Horikoshi M, Kim YJ, Lin K, Bragg F, Moon S, et al. Identification of type 2 diabetes loci in 433,540 East Asian individuals. Nature 2020;582:240-5.
PubMed PMC